ArticlePloS one2013
TTK/hMPS1 is an attractive therapeutic target for triple-negative breast cancer.
Virginie Maire et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
92 papers cite itlatest 60 shown
this paperpooled itcites it
ArticlePloS one2013
Virginie Maire et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.